top of page

The quickest way to measure human response in full physiology model.

PDE_edited.jpg

Zebrafish carrying human active sites, human targets and evaluated in clinical corresponding tests.

Target Modulation

Get Realtime feeback on Receptor Response

Efficacy Screening

Prove mechanism of action through dose response curves

neurons-brainstorm.jpg

Neurofibromatosis – Type 1  

Drug Discovery Challenge and Solutions

fat-red-blood-cells-blood-vessels-3d-rendering.jpg

Obesity Drug Discovery

Without off target CNS effect

Kinetics and Biodistribution

Know targeted delivery and off target accumulations

Phenotype Rescue

Target Deconvolution methods to demonstrate rescue

Picture8.png

  Selective Serotonin Reuptake Inhibitors

Managing Toxidromes

22006-01-cladogram-powerpoint-template-16x9-1.png

CART Screening

Overcoming Clonal Diversity

Aβ Aggregation Quantification

Image.jpg

Safety Toxicology

Picture5.png
NASH_edited.jpg

MASH

AI Workflows and Histology Grading

Picture17.png

Blood Brain Barrier

Brain/Plasma Ratios

Know early, Make decisions early !

Plan2.jpg

WHY ZEBRAFISH

Human disease course of several months happens in two weeks in zebrafish

Picture2

 Learn how zebrafish endpoints compare to humans and other research models.
 

Physiological parameter of Research Models-01.jpg

FDA Releases Draft Guidance on Alternatives to Animal Testing in Drug Development -March 18, 2026​

​​The 4 Validation Principles for Submission Criteria

Context of Use

Defines the exact scientific question the NAM answers (e.g., assessing hepatotoxicity during clinical trials or setting safe starting doses).

Human Biological Relevance

Requires sponsors to justify cell types, species of origin, and physiological features to prove the model mirrors human in vivo toxicity.

Technical Characterization

Demands rigorous documentation of assay parameters, limits of detection, reference compound controls, and sources of batch variability.

Fit-for-Purpose

Assures the data can directly drive regulatory drug reviews, either as a standalone alternative or within a broader total weight-of-evidence package.

Read how we drive change in your candidate development process

November 2024

Studying Protein Aggregates with Zebrafish

PolyQ Discovery Screening in Zebrafish.png
bottom of page